Semaglutide Explored as Potential Treatment for Polycystic Ovary Syndrome
Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy
Study Design
Population
Not specified in the digest.
Intervention
Semaglutide, dose, route, and duration not specified.
Outcome
Not specified in the digest.
Abstract
Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy
NCT ID: NCT06222437
Status: WITHDRAWN
Sponsor: Methodist Health System
Phase: PHASE1
Start: 2026-02 | Completion: 2027-02
Enrollment: 0 (ACTUAL)
Conditions: Polycy…